[HTML][HTML] The role of lipids and lipoproteins in atherosclerosis

MRF Linton, PG Yancey, SS Davies, WG Jerome… - Endotext …, 2019 - ncbi.nlm.nih.gov
Atherosclerosis is the underlying cause of heart attack and stroke. Early observations that
cholesterol is a key component of arterial plaques gave rise to the cholesterol hypothesis for …

Origin and physiological roles of inflammation

R Medzhitov - Nature, 2008 - nature.com
Inflammation underlies a wide variety of physiological and pathological processes. Although
the pathological aspects of many types of inflammation are well appreciated, their …

Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles

M Mackness, B Mackness - Gene, 2015 - Elsevier
Human PON1 is a HDL-associated lipolactonase capable of preventing LDL and cell
membrane oxidation and is therefore considered to be atheroprotective. PON1 contributes to …

Causes and metabolic consequences of fatty liver

N Stefan, K Kantartzis, HU Häring - Endocrine reviews, 2008 - academic.oup.com
Type 2 diabetes and cardiovascular disease represent a serious threat to the health of the
population worldwide. Although overall adiposity and particularly visceral adiposity are …

[HTML][HTML] Effect of torcetrapib on the progression of coronary atherosclerosis

SE Nissen, JC Tardif, SJ Nicholls… - … England Journal of …, 2007 - Mass Medical Soc
Background Levels of high-density lipoprotein (HDL) cholesterol are inversely related to
cardiovascular risk. Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor …

High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target

TF Lüscher, U Landmesser, A von Eckardstein… - Circulation …, 2014 - Am Heart Assoc
High-density lipoprotein (HDL) is a complex mixture of lipoproteins that is associated with
many minor proteins and lipids that influence the function of HDL. Although HDL is a …

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression …

M Briel, I Ferreira-Gonzalez, JJ You, PJ Karanicolas… - Bmj, 2009 - bmj.com
Objective To investigate the association between treatment induced change in high density
lipoprotein cholesterol and total death, coronary heart disease death, and coronary heart …

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein AI: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk …

WA van der Steeg, I Holme, SM Boekholdt… - Journal of the American …, 2008 - jacc.org
Objectives: This study was designed to assess the relationship of high-density-lipoprotein
cholesterol (HDL-C), HDL particle size, and apolipoprotein AI (apoA-I) with the occurrence of …

High-density lipoprotein as a therapeutic target: a systematic review

IM Singh, MH Shishehbor, BJ Ansell - Jama, 2007 - jamanetwork.com
ContextHigh-density lipoprotein cholesterol (HDL-C) is a cardiovascular risk factor that is
gaining substantial interest as a therapeutic target. ObjectivesTo review the current and …

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

R Frikke-Schmidt, BG Nordestgaard, MCA Stene… - Jama, 2008 - jamanetwork.com
Context Low levels of high-density lipoprotein (HDL) cholesterol are inversely related to
cardiovascular risk. Whether this is a causal effect is unclear. Objective To determine …